NOTE 11 - EQUITY TRANSACTIONS (Tables)

12 Months Ended

Dec. 31, 2017

Stockholders' Equity Note [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

During 2017, the Company estimated the fair value of the stock options at the date of each grant based on the following weighted average assumptions:

Risk-free interest rate	1.36% to 1.99		%
Expected life	5 years
Expected volatility	98.38% to 101.86		%
Dividend yield		0.00	%

Schedule of Stock Options Roll Forward [Table Text Block]

The following is a summary of the status of the Company’s outstanding options as of December 31, 2017 and changes during the year then ended:

	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value
As of December 31, 2016		20,715,000		$	0.143		2.08	$	261,220
Granted		6,900,000			0.097
Forfeited		(7,550,000	)		0.202
Surrendered		(1,977,500	)		0.128
As of December 31, 2017		18,087,500			0.102		3.72		-
Exercisable		17,762,500			0.103		3.79		-

Share-based Compensation, Stock Options, Activity [Table Text Block]

A summary of unvested stock option activity for the year ended December 31, 2017 is presented below:

	Number of Shares			Weighted Average Grant Date Fair Value
Non-vested balance as of December 31, 2016		1,075,000		$	0.11
Awarded		1,000,000			0.08
Vested		(250,000	)		0.06
Forfeited		(500,000	)		0.10
Surrendered		(1,000,000	)		0.1095
Non-vested balance as of December 31, 2017		325,000			0.08